Elaborate the therapeutic indications, mechanism of action and side effects of Metformin.
5 marks · directive: Elaborate
The core of a good answer
Metformin, a biguanide, is the main first-line drug for type 2 diabetes and is also used in prediabetes, polycystic ovary syndrome, gestational diabetes and to counter antipsychotic weight gain; it lowers blood glucose mainly by decreasing gluconeogenesis in the liver (proposed mechanisms include mitochondrial complex I inhibition and AMPK activation) and by increasing insulin sensitivity, with a small risk of hypoglycaemia and no weight gain, and its side effects are gastrointestinal irritation, vitamin B12 deficiency with higher doses and prolonged use, and rare lactic acidosis.
An outline written by upsc.help, not an official UPSC answer; every fact checked by a separate review. How we work
What the question asks
Three headings: indications with evidence, mechanism at organ and molecular level, and side effects with contraindications.
Answer outline
Introduction
Metformin is a biguanide anti-hyperglycaemic agent with a lower risk of hypoglycaemia than the sulfonylureas.
Therapeutic indications
- Type 2 diabetes: first-line drug, particularly in overweight patients; combined with other agents as disease progresses.
- Prediabetes: moderate-quality evidence that it reduces the risk of developing type 2 diabetes, though not when compared with intensive diet or exercise.
- Polycystic ovary syndrome: evidence on live birth rates is mixed; tentative evidence of benefit, but no conclusive improvement.
- Gestational diabetes: found to be as effective and safe as insulin.
- To counteract weight gain caused by the antipsychotics olanzapine and clozapine.
Mechanism of action
- Decreases gluconeogenesis (glucose production) in the liver.
- Proposed molecular basis: among multiple potential mechanisms, inhibition of mitochondrial complex I and activation of AMP-activated protein kinase (AMPK), which was required for its inhibitory effect on liver glucose output; some actions are AMPK-independent, and the mechanism is not completely understood.
- Increases insulin sensitivity and enhances peripheral glucose uptake.
- Increases GDF15 secretion, which reduces appetite and caloric intake; it is not associated with weight gain and is typically associated with weight loss.
- Small risk of hypoglycaemia, lower than with sulfonylureas; hypoglycaemia has uncommonly occurred during intense exercise or calorie deficit.
Side effects and contraindications
- Gastrointestinal: diarrhoea, cramps, nausea, vomiting and increased flatulence; slow or extended-release preparations may improve tolerability.
- Vitamin B12 deficiency, more frequent with higher doses and prolonged use.
- Lactic acidosis: rare, and seems related to impaired liver or kidney function or inadequate tissue oxygenation.
- Contraindications: eGFR below 30 mL/min/1.73 m2, metabolic acidosis including diabetic ketoacidosis, hypersensitivity.
Conclusion
Metformin's low hypoglycaemia risk and lack of weight gain keep it the first-line drug in type 2 diabetes.
Examples and data to cite
- In prediabetes, moderate-quality evidence shows metformin reduces the risk of type 2 diabetes, but not compared with intensive diet or exercise.
- Metformin has been found as effective and safe as insulin for gestational diabetes.
Facts to remember
- Metformin is the main first-line medication for type 2 diabetes.
- Metformin is contraindicated when eGFR is below 30 mL/min/1.73 m2.
- Long-term metformin use is associated with vitamin B12 malabsorption.
- Lactic acidosis with metformin is rare.